FDA approves Moderna’s mRNA-based vaccine: What you need to know
The Food and Drug Administration has reportedly approved a new kind of flu vaccine for older people: a pioneering mRNA formulation that was key to ending the acute phase of the COVID-19 pandemic.
The shot primarily named mFlusiva is indicated only for adults aged 50 or older. Meanwhile,........
